Cost Effectiveness of Dialysis Modalities: A Systematic Review of Economic Evaluations

被引:42
作者
Howell, Martin [1 ]
Walker, Rachael C. [2 ]
Howard, Kirsten [1 ]
机构
[1] Univ Sydney, Sydney Sch Publ Hlth, Fac Med & Hlth, Sydney, NSW, Australia
[2] Eastern Inst Technol, Napier, New Zealand
基金
英国医学研究理事会;
关键词
QUALITY-OF-LIFE; RENAL REPLACEMENT THERAPY; IN-CENTER HEMODIALYSIS; HIGH-DOSE HEMODIALYSIS; PERITONEAL-DIALYSIS; NOCTURNAL HEMODIALYSIS; UTILITY ANALYSIS; KIDNEY-DISEASE; HOME;
D O I
10.1007/s40258-018-00455-2
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background and ObjectiveThe economic burden of providing maintenance dialysis to those with end-stage kidney disease continues to increase. Home dialysis, including both haemodialysis and peritoneal dialysis, is commonly assumed to be more cost effective than facility dialysis, with some countries adopting a home-first policy in an attempt to reduce costs. However, the cost effectiveness of this approach is uncertain. The aim of this study is to review all published cost-effectiveness analyses comparing all alternative dialysis modalities for people with end-stage kidney disease.MethodsWe conducted a systematic review of MEDLINE, the National Health Service Economic Evaluation Database, and Health Technology Assessment Database from the Centre of Reviews and Dissemination, The Cochrane Library and Econlit from January 2000 to December 2017. Published economic evaluations were included if they provided comparative information on the costs and health outcomes of alternative dialysis modalities.ResultsThe review identified 16 economic evaluations comparing dialysis modalities from both high- and low-income countries. The majority (69%) were undertaken solely from the perspective of the payer or service provider, 14 (88%) included a cost-utility analysis and eight (50%) were modelled evaluations. The studies addressed costs and health outcomes of multiple dialysis modalities, with many reporting average cost effectiveness rather than incremental cost effectiveness. Almost all evaluations suggest home dialysis to be less costly and to offer comparable or better health outcomes than in-centre haemodialysis. However, the quality-of-life benefit for each modality was poorly defined and inconsistent in terms of magnitude and direction of differences between modalities and across studies. Other issues include exclusion of competing modalities and use of arbitrary assumptions with regard to the mix of modalities.ConclusionsThe ability to identify the mix of dialysis modalities that provides best outcomes for patients and health budgets is uncertain particularly given the lack of societal perspectives and inconsistencies between published studies.
引用
收藏
页码:315 / 330
页数:16
相关论文
共 50 条
  • [31] The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation
    Loveman, Emma
    Jones, Jeremy
    Clegg, Andrew J.
    Picot, Joanna
    Colquitt, Jillian L.
    Mendes, Diana
    Breen, David J.
    Moore, Emily
    George, Steve
    Poston, Graeme
    Cunningham, David
    Ruers, Theo
    Primrose, John
    HEALTH TECHNOLOGY ASSESSMENT, 2014, 18 (07) : 1 - +
  • [32] Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation
    Cummins, E.
    Royle, P.
    Snaith, A.
    Greene, A.
    Robertson, L.
    McIntyre, L.
    Waugh, N.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 (11) : 1 - +
  • [33] The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation
    Picot, J.
    Jones, J.
    Colquitt, J. L.
    Gospodarevskaya, E.
    Loveman, E.
    Baxter, L.
    Clegg, A. J.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 (41) : 1 - +
  • [34] Inborn errors of metabolism in neonates and pediatrics on varying dialysis modalities: a systematic review and meta-analysis
    Raina, Manan
    Doshi, Kush
    Myneni, Archana
    Tibrewal, Abhishek
    Gillen, Matthew
    Hu, Jieji
    Bunchman, Timothy E.
    PEDIATRIC NEPHROLOGY, 2024, : 2177 - 2188
  • [35] The Cost and Cost-Effectiveness of Childbirth Settings: A Systematic Review
    Scarf, Vanessa
    Kasaye, Habtamu
    Levett, Kate
    Callander, Emily
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2025,
  • [36] Economic evaluations of pancreatic cancer screening: a systematic review protocol
    Wittram, Robert
    Koenig, Hans-Helmut
    Brettschneider, Christian
    BMJ OPEN, 2024, 14 (08): : 1 - 6
  • [37] Biologicals and small molecules in psoriasis: A systematic review of economic evaluations
    Kromer, Christian
    Celis, Daniel
    Sonntag, Diana
    Peitsch, Wiebke K.
    PLOS ONE, 2018, 13 (01):
  • [38] Cost-effectiveness of hysterectomy for benign gynecological conditions: a systematic review
    Pynna, Kristiina
    Vuorela, Piia
    Lodenius, Leena
    Paavonen, Jorma
    Roine, Risto P.
    Rasanen, Pirjo
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2014, 93 (03) : 225 - 232
  • [39] The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model
    Fox, M.
    Mealing, S.
    Anderson, R.
    Dean, J.
    Stein, K.
    Price, A.
    Taylor, R. S.
    HEALTH TECHNOLOGY ASSESSMENT, 2007, 11 (47) : 1 - +
  • [40] What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation
    Leaviss, Joanna
    Sullivan, William
    Ren, Shijie
    Everson-Hock, Emma
    Stevenson, Matt
    Stevens, John W.
    Strong, Mark
    Cantrell, Anna
    HEALTH TECHNOLOGY ASSESSMENT, 2014, 18 (33) : 1 - +